Preoperative IV Iron in Benign Gynecologic Surgery: Reducing Transfusions and Improving Recovery
Anaemia is one of the most common and preventable risk factors in benign gynaecologic surgery. When a patient enters the operating theatre with low haemoglobin, even routine blood loss can increase the chance of allogeneic blood transfusion, delayed recovery, fatigue, and longer hospital stay.
That is why preoperative treatment of iron deficiency has become a key part of modern patient blood management. Recent research, including the linked study on benign gynaecologic surgery, adds to a growing body of evidence that intravenous iron before surgery can reduce transfusion exposure and support a safer recovery pathway.
The message is practical: when iron deficiency anaemia is found early enough, correcting it before surgery can change what happens after surgery.
Why anaemia matters before benign gynaecologic surgery
Benign gynaecologic surgery includes procedures such as hysterectomy, myomectomy, surgery for fibroids, and treatment for abnormal uterine bleeding. Many patients who need these operations already have iron deficiency because of chronic heavy menstrual bleeding.
That creates a difficult cycle:
Heavy bleeding lowers iron stores.
Low iron stores reduce haemoglobin production.
Surgery adds further blood loss.
The patient becomes more likely to need transfusion.
Blood transfusion can be lifesaving, and it remains essential in urgent or severe blood loss. Still, it is not a neutral intervention. Transfusions carry risks, including febrile reactions, allergic reactions, transfusion-associated circulatory overload, alloimmunisation, and infection risk, even though modern screening has made blood supply much safer.
For surgical teams, the goal is not to avoid transfusion at all costs. The goal is to prevent avoidable transfusion by reducing modifiable risk before the operation.
Preoperative anaemia is one of those modifiable risks.
What intravenous iron does differently
Iron therapy can be given orally or intravenously. Oral iron works for many patients, especially when surgery is several months away and the patient can tolerate the tablets. The challenge is that gynaecologic surgery is often scheduled within weeks, and oral iron may not correct haemoglobin fast enough.
Oral iron can also cause gastrointestinal side effects such as nausea, constipation, abdominal discomfort, and poor adherence. Some patients do not absorb oral iron well because of inflammation, gastrointestinal conditions, or ongoing blood loss.
Intravenous iron bypasses the gut and delivers iron directly into the bloodstream. This allows the bone marrow to use iron for red blood cell production more quickly. In surgical care, that speed matters.
Treatment approach | Where it fits best | Main limitation |
Oral iron | Mild iron deficiency when surgery is not immediate | Slower response and gastrointestinal side effects |
Intravenous iron | Moderate to severe iron deficiency, poor oral tolerance, or surgery within weeks | Requires infusion capacity and monitoring |
Blood transfusion | Acute bleeding, symptomatic severe anaemia, or urgent correction | Carries transfusion-related risks and uses scarce blood resources |
PREOPERATIVE INTRAVENOUS IRON is best understood as a blood conservation strategy, not as a replacement for transfusion when transfusion is clinically necessary.
What recent studies show
The linked study on benign gynaecologic surgery supports an important finding seen across patient blood management research: treating iron deficiency before surgery can reduce the need for perioperative transfusion.
While study designs differ, recent work in gynaecologic and broader surgical populations has shown several consistent patterns.
Patients receiving IV iron often have better haemoglobin readiness
Studies commonly find that patients who receive intravenous iron before surgery have improved haemoglobin levels by the time of operation or in the perioperative period. This is especially relevant for patients with iron deficiency anaemia caused by heavy uterine bleeding or fibroids.
A higher preoperative haemoglobin gives the patient more reserve. That means a similar amount of surgical blood loss is less likely to push the patient below a transfusion threshold.
The benefit is not only numerical. Patients with improved haemoglobin may experience less postoperative fatigue, better exercise tolerance, and a smoother return to daily activity.
Transfusion requirements tend to fall when anaemia is treated early
Recent studies have found that preoperative iron treatment, particularly intravenous iron, is associated with lower rates of blood transfusion in appropriately selected anaemic patients. The linked study adds credibility in the setting of benign gynaecologic procedures, where anaemia is often present but may be under-treated before surgery.
This matters because transfusion is usually triggered by a combination of haemoglobin level, symptoms, blood loss, and clinical status. If a patient starts at a higher haemoglobin level, the same surgery may no longer result in a transfusion need.
The effect is strongest when iron deficiency is identified before admission
Iron treatment works best when it is part of planned preoperative care, not an afterthought on the day of surgery. Earlier testing gives clinicians time to distinguish iron deficiency from other causes of anaemia and to select the right treatment.
A practical preoperative assessment usually includes:
Complete blood count
Serum ferritin
Transferrin saturation, where available
C-reactive protein when inflammation may affect ferritin interpretation
Review of bleeding history and medication use
When surgery is elective, this assessment can happen during the pre-anaesthesia or pre-surgical planning stage.
Why this matters for recovery
A transfusion outcome is more than a statistic. It affects how patients feel and how quickly they recover.
Anaemia after surgery can cause marked tiredness, dizziness, shortness of breath on exertion, palpitations, and reduced ability to mobilise. These symptoms can slow recovery even when the operation itself goes well.
Correcting iron deficiency before surgery may help recovery in several ways.
Better oxygen delivery
Haemoglobin carries oxygen to tissues. When haemoglobin is low, the body has less capacity to deliver oxygen during the stress of surgery and healing.
Improving haemoglobin before surgery gives tissues a better chance to cope with blood loss and inflammation. This may support wound healing, mobility, and overall postoperative strength.
Less exposure to transfusion-related harm
Avoiding unnecessary transfusion reduces exposure to potential complications. It also helps preserve blood supply for patients who need blood urgently, such as those with trauma, obstetric haemorrhage, major cancer surgery, or severe anaemia with instability.
This is especially relevant in healthcare systems where blood availability may fluctuate and demand is high.
More confidence in surgical planning
When anaemia is addressed before the procedure, surgeons and anaesthesiologists can plan with a clearer understanding of risk. It may influence the timing of surgery, the need for blood reservation, the choice of minimally invasive technique where suitable, and postoperative monitoring.
This does not mean every anaemic patient should receive IV iron. It means anaemia should be actively assessed and treated rather than accepted as a background problem.
Where intravenous iron fits in patient blood management
Patient blood management is a structured approach to reducing avoidable transfusion and improving outcomes. It usually rests on three pillars:
Treat anaemia before surgery
Reduce blood loss during surgery
Use blood transfusion only when clinically indicated
Intravenous iron fits mainly into the first pillar. In benign gynaecologic surgery, it is particularly relevant because iron deficiency is common, often predictable, and often treatable.
A typical pathway may look like this:
Screen for anaemia when surgery is being planned.
Confirm whether iron deficiency is present.
Use oral iron if time allows and the patient tolerates it.
Use intravenous iron when surgery is near, anaemia is moderate or severe, oral iron has failed, or oral iron is not tolerated.
Recheck haemoglobin when clinically appropriate.
Continue postoperative iron replacement if iron stores remain low.
The pathway should be adapted to the patient’s symptoms, haemoglobin level, urgency of surgery, comorbidities, and local protocols.
Practical implications for benign gynaecologic surgery
The evidence has clear implications for common procedures.
Hysterectomy for heavy menstrual bleeding
Patients undergoing hysterectomy for heavy bleeding may have long-standing iron deficiency. If anaemia is corrected before surgery, the chance of needing transfusion may fall, especially when blood loss is moderate rather than severe.
Minimally invasive surgery can also reduce blood loss where appropriate, but surgical technique and anaemia treatment should work together.
Myomectomy for fibroids
Fibroids can cause both chronic bleeding and operative blood loss. Myomectomy may carry higher bleeding risk than some other benign procedures because fibroids can be vascular.
In this setting, improving haemoglobin before surgery can provide a safety margin. Some patients may also need other preoperative measures to reduce bleeding, depending on clinical judgement.
Surgery after failed medical treatment
Patients may reach surgery after months or years of heavy bleeding despite medicines or hormonal devices. By that point, iron deficiency may be significant. Waiting until admission to address anaemia misses an opportunity to improve readiness for surgery.
Safety and patient selection
Modern intravenous iron preparations are generally well tolerated when given under appropriate supervision. Serious allergic reactions are uncommon, but infusion services should be equipped to monitor patients and manage reactions if they occur.
Common considerations before IV iron include:
Confirming iron deficiency or likely functional iron deficiency
Reviewing history of previous iron reactions
Checking for active infection when relevant
Avoiding unnecessary iron in patients without deficiency
Choosing dose and preparation based on local policy
Monitoring practices vary. Some centres give IV iron as a single larger dose, while others use divided doses. The right schedule depends on the formulation available, the haemoglobin deficit, body weight, timing of surgery, and institutional protocol.
The key safety principle is simple: treat the cause, use the right patient selection, and monitor appropriately.
What the linked study adds to clinical practice
The linked study is valuable because it focuses on benign gynaecologic surgery, a field where anaemia is common but may not always receive the same level of attention as blood loss in major cancer or cardiac surgery.
Its findings align with a wider shift in perioperative medicine. Rather than treating transfusion as the main response to perioperative anaemia, clinicians are increasingly treating anaemia as a preoperative condition that deserves early diagnosis.
The study also helps make the case for practical system changes:
Anaemia screening should occur early in the surgical pathway.
Iron studies should be ordered when haemoglobin is low or bleeding history suggests deficiency.
IV iron access should be available when oral iron is too slow or poorly tolerated.
Gynaecology, anaesthesia, haematology, and preoperative assessment teams should use shared protocols.
These steps can reduce variation in care. They also help ensure that anaemia treatment does not depend only on individual clinician preference.
What health systems can do next
For hospitals and surgical centres, the challenge is not only knowing that IV iron can help. The challenge is building a reliable process.
A good pathway should answer four questions:
When should haemoglobin be checked?
Ideally, at the time surgery is being considered or booked.
Who orders iron studies?
This may be the gynaecologist, anaesthesiologist, preoperative clinic, or a shared protocol.
Who receives IV iron?
Criteria should include haemoglobin level, iron studies, symptoms, timing of surgery, and tolerance of oral iron.
How is response followed?
Repeat haemoglobin testing should be planned when it will affect care.
Clear pathways also reduce last-minute cancellations. If anaemia is discovered only just before surgery, teams may face a difficult choice between proceeding with higher transfusion risk or postponing the operation. Early detection gives more options.
A safer path starts before the operation
Preoperative intravenous iron is not a minor add-on. For selected patients with iron deficiency anaemia undergoing benign gynaecologic surgery, it can be a meaningful part of safer surgical care.
The strongest lesson from recent studies, including the linked study, is that transfusion risk often begins before the incision. A patient with untreated anaemia enters surgery with less reserve. A patient whose iron deficiency has been recognised and treated enters with a better chance of avoiding transfusion and recovering with fewer setbacks.
For clinicians and surgical programmes, the next step is clear: screen early, identify iron deficiency, treat it before surgery where possible, and reserve transfusion for patients who truly need it.
This article is for informational purposes only and does not replace clinical judgement, local protocols, or individual medical advice.
Comments